| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| KALA BIO, Inc. | Director | Common Stock | 13.9K | $84.6K | $6.09 | Jun 11, 2024 | Direct |
| ACELRX PHARMACEUTICALS INC | Director | Common Stock | 5.29K | $3.85K | $0.73 | Oct 10, 2023 | Direct |
| KALA BIO, Inc. | Director | Common Stock | 165 | $1K | $6.09 | Jun 11, 2024 | Indirect |
| ACELRX PHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 3.49K | Oct 10, 2023 | Direct | ||
| KALA BIO, Inc. | Director | Stock Option (right to buy) | 3.15K | Jun 11, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Jun 11, 2024 | 2 | $0 | 4 | Jun 12, 2024 | Director |
| ACRX | ACELRX PHARMACEUTICALS INC | Oct 10, 2023 | 2 | $0 | 4 | Dec 13, 2023 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Jun 22, 2023 | 4 | $0 | 4 | Jun 23, 2023 | Director |
| KALA | Kala Pharmaceuticals, Inc. | May 31, 2023 | 6 | $0 | 4 | Jun 2, 2023 | Director |
| ACRX | ACELRX PHARMACEUTICALS INC | Jul 15, 2022 | 2 | $0 | 4 | Jul 15, 2022 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
| KALA | Kala Pharmaceuticals, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| ACRX | ACELRX PHARMACEUTICALS INC | Jun 17, 2021 | 2 | $0 | 4 | Jun 17, 2021 | Director |